Cumberland Pharmaceuticals (CPIX) Receivables (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Receivables of $14.3 million for Q1 2026, down 15.83% sequentially from $16.9 million in Q4 2025, and up 35.98% YoY from $10.5 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Receivables (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Receivables for 17 years, with the latest figure at $14.3 million in Q1 2026.
- Quarterly Receivables rose 35.98% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 35.98% YoY) and the FY2025 annual result came in at $16.9 million, up 44.81% from the prior year.
- Receivables declined to $14.3 million in Q1 2026 per CPIX's latest filing, from $16.9 million in the prior quarter.
- Over five years, Receivables peaked at $16.9 million in Q4 2025 and troughed at $9.8 million in Q4 2023.
- A 5-year average of $12.5 million and a median of $12.2 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2024: Receivables jumped 91.41% in 2022, then declined 26.72% in 2024.
- Over 5 years, Receivables stood at $13.2 million in 2022, then fell by 25.87% to $9.8 million in 2023, then rose by 19.91% to $11.7 million in 2024, then surged by 44.81% to $16.9 million in 2025, then retreated by 15.83% to $14.3 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $14.3 million, $16.9 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 1.08 Bn |
| 10 | Cumberland Pharmaceuticals | 117.08 Mn | 113.22 Mn | - | 13.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.42 Mn |
| Mar 31, 2026 | 14.26 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | 10.43 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 10.49 Mn |
| Dec 31, 2024 | 11.70 Mn |
| Sep 30, 2024 | 11.31 Mn |
| Jun 30, 2024 | 11.62 Mn |
| Mar 31, 2024 | 10.65 Mn |
| Dec 31, 2023 | 9.76 Mn |
| Sep 30, 2023 | 12.62 Mn |
| Jun 30, 2023 | 12.22 Mn |
| Mar 31, 2023 | 14.53 Mn |
| Dec 31, 2022 | 13.16 Mn |
| Sep 30, 2022 | 15.23 Mn |
| Jun 30, 2022 | 13.28 Mn |
| Mar 31, 2022 | 14.64 Mn |
| Dec 31, 2021 | 6.88 Mn |
| Sep 30, 2021 | 9.85 Mn |